| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.31 | 3e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-06 |